2004
DOI: 10.1002/prot.10590
|View full text |Cite
|
Sign up to set email alerts
|

A structural and dynamic model for the interaction of interleukin‐8 and glycosaminoglycans: Support from isothermal fluorescence titrations

Abstract: Binding of interleukin-8 (IL-8) to glycosaminoglycans (GAGs) on the surface of endothelial cells is crucial for the recruitment of neutrophils to an inflammatory site. Deriving structural knowledge about this interaction from in silico docking experiments has proved difficult because of the high flexibility and the size of GAGs. Therefore, we developed a docking method that takes into account ligand and protein flexibility by running approximately 15,000 molecular dynamics simulations of the docking event with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
59
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(65 citation statements)
references
References 45 publications
5
59
1
Order By: Relevance
“…Mutations were performed to replace the GAG-binding residues (R20A/R60A/K65A/K67A/ R68A), the cysteine residues (C7S/C9S/C34S/C50S), and the residues encompassing the 3 10 on the solvent-exposed surface (33,35,37), they do have notable differences. For example, both helices interact with GAGs, but the main GAG-binding sites are located in different positions (30,38,39 20 ) with alanine did not affect sorting, suggesting that the positively charged residues of the ␣-helix involved in GAG binding are not important for targeting to WPB. It cannot be excluded that the remaining surface-exposed residues of the ␣-helix contribute to sorting by interaction with specific receptor molecules.…”
Section: Discussionmentioning
confidence: 97%
“…Mutations were performed to replace the GAG-binding residues (R20A/R60A/K65A/K67A/ R68A), the cysteine residues (C7S/C9S/C34S/C50S), and the residues encompassing the 3 10 on the solvent-exposed surface (33,35,37), they do have notable differences. For example, both helices interact with GAGs, but the main GAG-binding sites are located in different positions (30,38,39 20 ) with alanine did not affect sorting, suggesting that the positively charged residues of the ␣-helix involved in GAG binding are not important for targeting to WPB. It cannot be excluded that the remaining surface-exposed residues of the ␣-helix contribute to sorting by interaction with specific receptor molecules.…”
Section: Discussionmentioning
confidence: 97%
“…However, IL-8 greatly differs from IL-18 at both the sequence and structural level. Amino acids involved in IL-8-GAG binding have been identified as the basic amino acids His-18, Arg-60, Lys-64, Lys-67, and Arg68, located in the Cterminal helix and Lys20 in the proximal loop (48). The rank order of these residues' contributions to GAG binding is Lys-64, Arg-60, Lys-20, Lys-67, Arg-68, and His18.…”
Section: Discussionmentioning
confidence: 99%
“…2 Residues containing atoms within 3.5 Å of ligand in the 5 lowest energy complexes ... [1] ... [3] Page 17 of 34 http://mc.manuscriptcentral.com/tandf/jenmol 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 2 Residues containing atoms within 3.5 Å of ligand in the 5 lowest energy complexes Table 3: Prediction of heparin binding to the interferon/IL10 group of 4-helical cytokines. ... [7] ... [19] ... [15] ... [20] ... [18] ... [17] ... [21] ... [5] ... [22] ... [6] ... [16] ... [13] ... [24] ... [8] ... [25] ... [23] ... [14] ... [26] ... [9] ... [27] ... …”
Section: Discussionmentioning
confidence: 99%
“…Several groups have developed protocols for a systematic search of the entire surface of a protein to find the best heparin binding site [20][21][22]. We have used a combination of predictive docking with experimental studies in the successful identification of several heparin binding sites [23][24][25].…”
Section: Drug Discovery Techniquesmentioning
confidence: 99%